Ropes & Gray represented Evergreen Nephrology, a leader in value-based kidney care, in the company’s $130 million fund raise led by Rubicon Founders, Oak HC/FT, and a group of existing investors with the addition of K2 HealthVentures. The transaction was announced in a Jan. 7 press release.
Evergreen Nephrology partners with nephrologists and payors to provide care for patients with chronic and end-stage kidney disease. Operating across 24 states with a network of over 900 providers, Evergreen delivers personalized, value-based care designed to empower patients and improve outcomes.
The team was led by finance partner Greg Bauer, venture capital & emerging companies partner Brad Flint, executive compensation & employee benefits partner Pascal Mayer, tax partners Pam Glazier and Tristan Evans-Wilent, and health care partner Devin Cohen.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.